About this file

This document outlines protocols for a clinical study being conducted under a federal contract with the Food and Drug Administration. The study aims to assess tobacco-related clinical outcomes and human behaviors in tobacco users. It involves developing protocols for statistical analysis, clinical studies, and laboratory testing. Key activities include drafting a statistical analysis plan, clinical and laboratory protocols, conducting internal scientific reviews, submitting documents for institutional review board approval, manipulating synthetic cooling agents for testing, collecting and analyzing biosamples and clinical data, drafting final reports, and performing stability testing of stock solutions and cigarettes throughout the study period. The related federal contract opportunity is a solicitation issued by the Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services to conduct this clinical research study assessing tobacco use outcomes and behaviors.

View the file

Other files

File Type Posted
Task order 2-Attachnent 4.pdf PDF
SF 1449 75F40123R00028.pdf PDF
Attachment 2 (1).pdf PDF
Attachment 1.docx DOCX document
Jackson et al attachment 5.pdf PDF
RFP 75F40123R00028.pdf PDF
Task order 1-Attachment 3.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

FDA Synthetic Cooling Agent Study

Contract Kick-off

Draft Protocols (assuming 3 rounds of review: ~4 months)

Statistical Analysis Plan

ITP Submission

Final v1.0 SAP

Draft Clinical Protocol

SGE Review ~2 months

Internal Scientific Review

~1 month

ITP Submission ~1 month

CTP RIHSC Review ~1 month

IRB Review ~1 month

Final v1.0 Clinical Protocol

Draft Laboratory Protocol

Order Laboratory Study Materials

ITP Submission

Final v1.0 Laboratory Protocol

FDA Synthetic Cooling Agent Study

Final Protocols

NIDA DSP Submission for SPECTRUM (requires ITP and IRB approvals, final protocol and ICF) ~2 months

Begin SPECTRUM manipulation and testing

(requires 5 days of stability testing at multiple timepoints)

Submit data to FDA

Perform Clinical Study / Data Collection

Biosample analysis Drafting of Final Reports

Submit Final Reports

Conduct stabilty testing of stock solutions and cigarettes throughout clinical study

File details come from the government source that posted it. Updated .